Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
measles vaccine (Bio Farma)
- Development stage
- Unknown
- Lead developer
- Bio Farma
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Subcutaneous
01
Overview
Bio Farma's measles vaccine is a live attenuated vaccine developed and manufactured by PT Bio Farma (Persero) in Indonesia. It is indicated for the active immunization against measles virus infection. The vaccine is provided as a lyophilized powder that requires reconstitution with water for injection and is typically administered subcutaneously. It has been WHO prequalified since 2006 and is widely distributed globally through organizations like UNICEF and PAHO. The vaccine works by inducing a protective immune response, including the production of neutralizing antibodies and cellular immunity against the measles virus.
- Brand names
- Measles Vaccine Bio Farma
- Other names
- Campak vaccineBio Farma Measles Vaccine
Beyond the preview
Go deeper on measles vaccine (Bio Farma).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on measles vaccine (Bio Farma).